Question 1

What is Inflammatix?

Accepted Answer

Inflammatix is a company developing rapid point-of-care diagnostic tests that read the immune response to help physicians better diagnose acute infections and sepsis.

Question 2

What is the Triverity test?

Accepted Answer

The Triverity test is Inflammatix's product that interprets the immune response to inform on key clinically actionable questions, such as whether the patient has a bacterial or viral infection or a noninfectious condition, and whether the patient is likely to need ICU-level intervention.

Question 3

What is the significance of the immune response in diagnosing acute infections and sepsis?

Accepted Answer

The power of the immune response can be used to diagnose acute infections and sepsis, which is crucial as emergency departments across the US routinely see patients suspected of these conditions, but in up to half of these patients, physicians struggle to make proper diagnosis and prognosis.

Question 4

What stage of development are Inflammatix's products in?

Accepted Answer

Inflammatix's products are currently in development and are not yet for sale or approved by regulatory authorities.

Question 5

What is Inflammatix's goal in developing these diagnostic tests?

Accepted Answer

Inflammatix's goal is to provide novel tools to assist emergency medicine physicians in evaluating and properly diagnosing patients with suspected acute infections or sepsis, for whom current diagnostic methods are often insufficient.

Inflammatix

Company Overview

Company Name

Address

Website

Phone

About Inflammatix

Frequently Asked Questions about Inflammatix

What is Inflammatix?

What is the Triverity test?

What is the significance of the immune response in diagnosing acute infections and sepsis?

What stage of development are Inflammatix's products in?

What is Inflammatix's goal in developing these diagnostic tests?

Technologies Used

Social Profiles

Key Decision Makers